Anaesthesia for adults with cystic fibrosis

A M Weeks1, M R Buckland

  • 1Alfred Group of Hospitals, Prahran, Victoria.

Insights

Cystic fibrosis (CF) patients, even with severe respiratory issues, can undergo procedures safely with careful anesthetic management. Optimal pre- and postoperative care, focusing on airway clearance, is crucial for minimizing risks in CF patients.

Area of Science:

  • Anesthesiology
  • Pulmonology
  • Genetics

Background:

  • Cystic fibrosis (CF) is a genetic disorder affecting multiple organ systems, primarily the lungs and gastrointestinal tract.
  • Increased survival of CF patients into adulthood necessitates specialized anesthetic care for various procedures.
  • Common CF complications like severe respiratory disease, diabetes, and reflux pose challenges for anesthesiologists.

Purpose of the Study:

  • To describe the anesthetic management and perioperative care of cystic fibrosis patients.
  • To evaluate the safety and outcomes of surgical procedures in CF patients.
  • To highlight the importance of multidisciplinary care for cystic fibrosis patients undergoing anesthesia.

Main Methods:

  • Retrospective cohort study of 74 cystic fibrosis patients undergoing 149 procedures.
  • Data collected from January 1978 to January 1994 at Alfred Hospital.
  • Analysis of anesthetic techniques and perioperative management strategies.

Main Results:

  • Overall mortality was 0.6% for all procedures and 1% for postoperative mortality.
  • Procedures included CF-related interventions (diagnostic, venous access, feeding tubes, complication management, lung transplantation) and unrelated conditions.
  • Patients with compromised respiratory function were managed with acceptable low mortality.

Conclusions:

  • Cystic fibrosis patients can undergo surgical procedures with low mortality when managed with appropriate anesthetic and perioperative strategies.
  • Effective clearance of respiratory secretions is paramount in pre- and postoperative care.
  • Careful planning and a multidisciplinary team approach are essential for optimal outcomes in cystic fibrosis patients.

Related Concept Videos

General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...